chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Platelet disorder
Clinical narrative: Platelets dropped to 3000. Went to ER.  Given 2 units of platelets immediately and omitted for 9 days of treatments.   Received a call from my doctor urging me to get to the ER immediately after receiving my quarterly blood work. Other than feeling somewhat fatigue I presented no symptoms. I was a walking time bond and in very serious danger of a bleed out. This was 9 days after my 2nd injection.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Blood test, Dizziness, Electrocardiogram, Pharyngeal swelling
Clinical narrative: nerve problems behind left eye; nerve problems in face; lips had nerve problems; tongue was numb; throat felt swollen; Bell's palsy; lightheaded and dizzy; This is a spontaneous report received from a contactable consumer (who is also the patient). A 59-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207), via an unspecified route of administration in the left arm, on 11Mar2021 15:30, as single dose, for covid-19 immunisation. Medical history included known allergies to antihistamine (unspecified) and sulfur drugs. The patient was not pregnant at the time of vaccination. The patient did not have COVID-19 prior the vaccination and was not tested for COVID-19 post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID); omeprazole; and anastrozole, all taken for unspecified indications, start and stop dates were not reported. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) received at age 59 years, via an unspecified route of administration in the left arm, on 18Feb2021 15:45, for COVID-19 immunization. The patient did not receive other vaccines in four weeks. On 11Mar2021 at 15:45, 15 minutes after the second dose, the patient got lightheaded and dizzy. On the same day at 16:15, 45 minutes after the second dose, the patient experienced nerve problems behind left eye, then nerve problems in face, then lips had nerve problems, then tongue was numb, and throat felt swollen. The patient reported the side effects on the hotline, and she was transferred to a nurse who told her to go to the emergency room immediately as she could be getting Bell's palsy from the vaccine. The events resulted to emergency room visit and hospitalization (unspecified date in Mar2021). Treatment for the events included unspecified IV. The patient was hooked up to an EKG and her blood was drawn for checking in Mar2021 (results were unknown). The patient was recovering from the events.  Follow-up attempts are completed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Blood test, Dizziness, Electrocardiogram, Facial nerve disorder
Clinical narrative: nerve problems behind left eye; nerve problems in face; lips had nerve problems; tongue was numb; throat felt swollen; Bell's palsy; lightheaded and dizzy; This is a spontaneous report received from a contactable consumer (who is also the patient). A 59-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207), via an unspecified route of administration in the left arm, on 11Mar2021 15:30, as single dose, for covid-19 immunisation. Medical history included known allergies to antihistamine (unspecified) and sulfur drugs. The patient was not pregnant at the time of vaccination. The patient did not have COVID-19 prior the vaccination and was not tested for COVID-19 post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID); omeprazole; and anastrozole, all taken for unspecified indications, start and stop dates were not reported. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) received at age 59 years, via an unspecified route of administration in the left arm, on 18Feb2021 15:45, for COVID-19 immunization. The patient did not receive other vaccines in four weeks. On 11Mar2021 at 15:45, 15 minutes after the second dose, the patient got lightheaded and dizzy. On the same day at 16:15, 45 minutes after the second dose, the patient experienced nerve problems behind left eye, then nerve problems in face, then lips had nerve problems, then tongue was numb, and throat felt swollen. The patient reported the side effects on the hotline, and she was transferred to a nurse who told her to go to the emergency room immediately as she could be getting Bell's palsy from the vaccine. The events resulted to emergency room visit and hospitalization (unspecified date in Mar2021). Treatment for the events included unspecified IV. The patient was hooked up to an EKG and her blood was drawn for checking in Mar2021 (results were unknown). The patient was recovering from the events.  Follow-up attempts are completed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Nervous system disorder, Optic nerve disorder, Pharyngeal swelling
Clinical narrative: nerve problems behind left eye; nerve problems in face; lips had nerve problems; tongue was numb; throat felt swollen; Bell's palsy; lightheaded and dizzy; This is a spontaneous report received from a contactable consumer (who is also the patient). A 59-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207), via an unspecified route of administration in the left arm, on 11Mar2021 15:30, as single dose, for covid-19 immunisation. Medical history included known allergies to antihistamine (unspecified) and sulfur drugs. The patient was not pregnant at the time of vaccination. The patient did not have COVID-19 prior the vaccination and was not tested for COVID-19 post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID); omeprazole; and anastrozole, all taken for unspecified indications, start and stop dates were not reported. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) received at age 59 years, via an unspecified route of administration in the left arm, on 18Feb2021 15:45, for COVID-19 immunization. The patient did not receive other vaccines in four weeks. On 11Mar2021 at 15:45, 15 minutes after the second dose, the patient got lightheaded and dizzy. On the same day at 16:15, 45 minutes after the second dose, the patient experienced nerve problems behind left eye, then nerve problems in face, then lips had nerve problems, then tongue was numb, and throat felt swollen. The patient reported the side effects on the hotline, and she was transferred to a nurse who told her to go to the emergency room immediately as she could be getting Bell's palsy from the vaccine. The events resulted to emergency room visit and hospitalization (unspecified date in Mar2021). Treatment for the events included unspecified IV. The patient was hooked up to an EKG and her blood was drawn for checking in Mar2021 (results were unknown). The patient was recovering from the events.  Follow-up attempts are completed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Headache, Mouth swelling, Rash, Urticaria
Clinical narrative: I immediately had a sore throat, a burn/blister spot on roof of my mouth and an instant headache. I felt like I was developing hives and felt odd.  The shot also burned as it entered my arm.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Headache, Oral mucosal blistering, Oropharyngeal pain, Skin burning sensation
Clinical narrative: I immediately had a sore throat, a burn/blister spot on roof of my mouth and an instant headache. I felt like I was developing hives and felt odd.  The shot also burned as it entered my arm.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Catheterisation cardiac, Chest pain, Troponin
Clinical narrative: Thursday, March 25th at 3:10pm I received my 2nd dose of the Pfizer vaccine. Thursday, March 25th at 9pm I had cold chills, headache, low grade fever, diarrhea, and fatigue. These symptoms lasted Thursday night, Friday, Saturday (March 25th - March 28th). Sunday, March 29th at 4am I woke up with severe chest pains, shortness of breath and light headed. At this time I went to the emergency room.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bacterial test negative, Blood test, Chest pain, Chills, Diarrhoea
Clinical narrative: Thursday, March 25th at 3:10pm I received my 2nd dose of the Pfizer vaccine. Thursday, March 25th at 9pm I had cold chills, headache, low grade fever, diarrhea, and fatigue. These symptoms lasted Thursday night, Friday, Saturday (March 25th - March 28th). Sunday, March 29th at 4am I woke up with severe chest pains, shortness of breath and light headed. At this time I went to the emergency room.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Echocardiogram, Electrocardiogram, Fatigue
Clinical narrative: Thursday, March 25th at 3:10pm I received my 2nd dose of the Pfizer vaccine. Thursday, March 25th at 9pm I had cold chills, headache, low grade fever, diarrhea, and fatigue. These symptoms lasted Thursday night, Friday, Saturday (March 25th - March 28th). Sunday, March 29th at 4am I woke up with severe chest pains, shortness of breath and light headed. At this time I went to the emergency room.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Myocarditis, Pericarditis, Pyrexia
Clinical narrative: Thursday, March 25th at 3:10pm I received my 2nd dose of the Pfizer vaccine. Thursday, March 25th at 9pm I had cold chills, headache, low grade fever, diarrhea, and fatigue. These symptoms lasted Thursday night, Friday, Saturday (March 25th - March 28th). Sunday, March 29th at 4am I woke up with severe chest pains, shortness of breath and light headed. At this time I went to the emergency room.
Age: 73.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Chills, Dizziness, Loss of consciousness, Nausea, Vomiting
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient called to inform us she had a reaction after her second moderna dose. She said she felt dizzy about 17 hours later and lost consciousness for a few minutes at home. She said she will followup with her doctor to get checked out.
Age: 73.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Dizziness, Loss of consciousness, Syncope
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient called to inform us she had a reaction after her second moderna dose. She said she felt dizzy about 17 hours later and lost consciousness for a few minutes at home. She said she will followup with her doctor to get checked out.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Deafness, Tinnitus
Clinical narrative: Acute onset of tinnitus and hearing loss.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Audiogram abnormal, Deafness, Tinnitus
Clinical narrative: Acute onset of tinnitus and hearing loss.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Angiogram cerebral, Magnetic resonance imaging head, Superior sagittal sinus thrombosis
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood fibrinogen, Cerebral haemorrhage, Computerised tomogram head, Fibrin D dimer, Magnetic resonance imaging head
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count, Seizure, Superior sagittal sinus thrombosis, Thrombocytopenia
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Antinuclear antibody negative, Aspartate aminotransferase increased, Beta-2 glycoprotein antibody positive, Blood culture negative
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood fibrinogen decreased, Blood lactic acid, Blood thyroid stimulating hormone normal, Cerebral infarction, Cerebral venous sinus thrombosis
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Coma scale, Double stranded DNA antibody, Fibrin D dimer, Human chorionic gonadotropin negative, Immunoglobulin therapy
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: International normalised ratio increased, Mechanical ventilation, Nausea, Platelet count decreased, Staphylococcal infection
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Staphylococcus test positive, Thrombectomy, Thrombocytopenia, Thyroxine free normal, Vomiting
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: White blood cell count normal
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Brain operation, Cerebral haemorrhage, Cerebrovascular accident, Coma, Loss of personal independence in daily activities
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Mechanical ventilation, Seizure, Thrombosis, Wheelchair user
Clinical narrative: Johnson and Johnson. Patient developed nausea and vomiting and was diagnosed with intracerebral venous sinus thrombosis with infarcts.  Severe thrombocytopenia on presentation.  RX with IVIG initially x 2. She transferred to Medical Center after interventional thrombectomies. She is on heparin, ventilatory support with GCS 7 Will need trach and PEG soon.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Echocardiogram, Fibrin D dimer, Laboratory test, Scan with contrast
Clinical narrative: TACHYCARDIA; SHORTNESS OF BREATH; ACHINESS; This spontaneous report received from a parent concerned a 26 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered on 02-APR-2021 at 10:15 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 02-APR-2021, the subject experienced achiness. Laboratory data included: Heart rate (NR: not provided) 111 {beats}/min. On 02-APR-2021 20:00, the subject experienced tachycardia. On 02-APR-2021 20:00, the subject experienced shortness of breath. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tachycardia on 03-APR-2021 20:00, shortness of breath on 03-APR-2021, and achiness on APR-2021. This report was non-serious..; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachycardia, X-ray
Clinical narrative: TACHYCARDIA; SHORTNESS OF BREATH; ACHINESS; This spontaneous report received from a parent concerned a 26 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered on 02-APR-2021 at 10:15 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 02-APR-2021, the subject experienced achiness. Laboratory data included: Heart rate (NR: not provided) 111 {beats}/min. On 02-APR-2021 20:00, the subject experienced tachycardia. On 02-APR-2021 20:00, the subject experienced shortness of breath. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tachycardia on 03-APR-2021 20:00, shortness of breath on 03-APR-2021, and achiness on APR-2021. This report was non-serious..; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Heart rate, Pain, Tachycardia
Clinical narrative: TACHYCARDIA; SHORTNESS OF BREATH; ACHINESS; This spontaneous report received from a parent concerned a 26 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered on 02-APR-2021 at 10:15 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 02-APR-2021, the subject experienced achiness. Laboratory data included: Heart rate (NR: not provided) 111 {beats}/min. On 02-APR-2021 20:00, the subject experienced tachycardia. On 02-APR-2021 20:00, the subject experienced shortness of breath. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tachycardia on 03-APR-2021 20:00, shortness of breath on 03-APR-2021, and achiness on APR-2021. This report was non-serious..; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chest pain, Chills, Dyspnoea, Feeling abnormal
Clinical narrative: HEART RACING; SWEATING; CHEST PAIN TIGHTNESS; BRAIN FOG; FLU-LIKE SYMPTOMS SWEATS, HEADACHE, BODY ACHES, WEAKNESS, JOINT PAIN, MUSCLES ACHES, FATIGUE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, seasonal allergy, and contrast dye allergy. The patient experienced drug allergy when treated with ciprofloxacin for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21/JUN/2021) dose was not reported, administered on 31-MAR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced heart racing. On 31-MAR-2021, the subject experienced sweating. On 31-MAR-2021, the subject experienced chest pain tightness. On 31-MAR-2021, the subject experienced brain fog. On 31-MAR-2021, the subject experienced flu-like symptoms sweats, headache, body aches, weakness, joint pain, muscles aches, fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart racing, and sweating on 31-MAR-2021, was recovering from flu-like symptoms sweats, headache, body aches, weakness, joint pain, muscles aches, fatigue, and had not recovered from chest pain tightness, and brain fog. This report was non-serious.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Influenza like illness, Myalgia, Pain, Palpitations
Clinical narrative: HEART RACING; SWEATING; CHEST PAIN TIGHTNESS; BRAIN FOG; FLU-LIKE SYMPTOMS SWEATS, HEADACHE, BODY ACHES, WEAKNESS, JOINT PAIN, MUSCLES ACHES, FATIGUE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, seasonal allergy, and contrast dye allergy. The patient experienced drug allergy when treated with ciprofloxacin for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21/JUN/2021) dose was not reported, administered on 31-MAR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced heart racing. On 31-MAR-2021, the subject experienced sweating. On 31-MAR-2021, the subject experienced chest pain tightness. On 31-MAR-2021, the subject experienced brain fog. On 31-MAR-2021, the subject experienced flu-like symptoms sweats, headache, body aches, weakness, joint pain, muscles aches, fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart racing, and sweating on 31-MAR-2021, was recovering from flu-like symptoms sweats, headache, body aches, weakness, joint pain, muscles aches, fatigue, and had not recovered from chest pain tightness, and brain fog. This report was non-serious.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: HEART RACING; SWEATING; CHEST PAIN TIGHTNESS; BRAIN FOG; FLU-LIKE SYMPTOMS SWEATS, HEADACHE, BODY ACHES, WEAKNESS, JOINT PAIN, MUSCLES ACHES, FATIGUE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, seasonal allergy, and contrast dye allergy. The patient experienced drug allergy when treated with ciprofloxacin for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21/JUN/2021) dose was not reported, administered on 31-MAR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced heart racing. On 31-MAR-2021, the subject experienced sweating. On 31-MAR-2021, the subject experienced chest pain tightness. On 31-MAR-2021, the subject experienced brain fog. On 31-MAR-2021, the subject experienced flu-like symptoms sweats, headache, body aches, weakness, joint pain, muscles aches, fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart racing, and sweating on 31-MAR-2021, was recovering from flu-like symptoms sweats, headache, body aches, weakness, joint pain, muscles aches, fatigue, and had not recovered from chest pain tightness, and brain fog. This report was non-serious.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Feeling abnormal, Hyperhidrosis, Influenza like illness, Palpitations
Clinical narrative: HEART RACING; SWEATING; CHEST PAIN TIGHTNESS; BRAIN FOG; FLU-LIKE SYMPTOMS SWEATS, HEADACHE, BODY ACHES, WEAKNESS, JOINT PAIN, MUSCLES ACHES, FATIGUE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, seasonal allergy, and contrast dye allergy. The patient experienced drug allergy when treated with ciprofloxacin for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21/JUN/2021) dose was not reported, administered on 31-MAR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced heart racing. On 31-MAR-2021, the subject experienced sweating. On 31-MAR-2021, the subject experienced chest pain tightness. On 31-MAR-2021, the subject experienced brain fog. On 31-MAR-2021, the subject experienced flu-like symptoms sweats, headache, body aches, weakness, joint pain, muscles aches, fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart racing, and sweating on 31-MAR-2021, was recovering from flu-like symptoms sweats, headache, body aches, weakness, joint pain, muscles aches, fatigue, and had not recovered from chest pain tightness, and brain fog. This report was non-serious.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Cough, Feeling jittery, Flushing
Clinical narrative: Within 10 mins extreme coughing, high heart rate, dizzy and headache. Administration of .3 Epi cia Epi pen, called 911 O2 normal, heart rate and BP high, throat constriction and bringing sounds of upper chest wheezing( via paramedic) Ambulance to hospital, another .3 Epi and 50 IV Benedyl,  Symptoms began to lessens. First EKG showed tachycardia, but repeated was clear. 5 days of 50 mg prednisone, and famotidine were completed. On day 6 symptoms reappeared and after 3 hrs of heart rate in the 130/140?s and coughing, and shaking a repeat visits to ER was made. All cardio labs and chest X-ray were clear, more famotadine was given with Atavan and steroids. Prescription for 7 days of prednisone was given and has been started. Day 7 /Day 1 of second round of steroids and some symptoms are returning..itching and tightness in chest, coughing and elevated heart rate. Taking antihistamines.  This is current for today
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest X-ray, Chest discomfort, Cough, Dizziness
Clinical narrative: Within 10 mins extreme coughing, high heart rate, dizzy and headache. Administration of .3 Epi cia Epi pen, called 911 O2 normal, heart rate and BP high, throat constriction and bringing sounds of upper chest wheezing( via paramedic) Ambulance to hospital, another .3 Epi and 50 IV Benedyl,  Symptoms began to lessens. First EKG showed tachycardia, but repeated was clear. 5 days of 50 mg prednisone, and famotidine were completed. On day 6 symptoms reappeared and after 3 hrs of heart rate in the 130/140?s and coughing, and shaking a repeat visits to ER was made. All cardio labs and chest X-ray were clear, more famotadine was given with Atavan and steroids. Prescription for 7 days of prednisone was given and has been started. Day 7 /Day 1 of second round of steroids and some symptoms are returning..itching and tightness in chest, coughing and elevated heart rate. Taking antihistamines.  This is current for today
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Headache, Heart rate increased, Hypertension, Pruritus
Clinical narrative: Within 10 mins extreme coughing, high heart rate, dizzy and headache. Administration of .3 Epi cia Epi pen, called 911 O2 normal, heart rate and BP high, throat constriction and bringing sounds of upper chest wheezing( via paramedic) Ambulance to hospital, another .3 Epi and 50 IV Benedyl,  Symptoms began to lessens. First EKG showed tachycardia, but repeated was clear. 5 days of 50 mg prednisone, and famotidine were completed. On day 6 symptoms reappeared and after 3 hrs of heart rate in the 130/140?s and coughing, and shaking a repeat visits to ER was made. All cardio labs and chest X-ray were clear, more famotadine was given with Atavan and steroids. Prescription for 7 days of prednisone was given and has been started. Day 7 /Day 1 of second round of steroids and some symptoms are returning..itching and tightness in chest, coughing and elevated heart rate. Taking antihistamines.  This is current for today
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness, Wheezing
Clinical narrative: Within 10 mins extreme coughing, high heart rate, dizzy and headache. Administration of .3 Epi cia Epi pen, called 911 O2 normal, heart rate and BP high, throat constriction and bringing sounds of upper chest wheezing( via paramedic) Ambulance to hospital, another .3 Epi and 50 IV Benedyl,  Symptoms began to lessens. First EKG showed tachycardia, but repeated was clear. 5 days of 50 mg prednisone, and famotidine were completed. On day 6 symptoms reappeared and after 3 hrs of heart rate in the 130/140?s and coughing, and shaking a repeat visits to ER was made. All cardio labs and chest X-ray were clear, more famotadine was given with Atavan and steroids. Prescription for 7 days of prednisone was given and has been started. Day 7 /Day 1 of second round of steroids and some symptoms are returning..itching and tightness in chest, coughing and elevated heart rate. Taking antihistamines.  This is current for today
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Hypoaesthesia oral, Lip pruritus, Paraesthesia
Clinical narrative: Pt received shot at 1626. At 1637, pt reported that her lower lip felt itchy, cheeks were red. Pt has hx anaphylaxis to multiple food allergies and carries epi pen with her. At 1638, VS: BP 168/112, P 86, O2 100% RA.Lungs clear bilaterally. Pt then reported that her tongue felt ?numb? and ?pins and needles? sensations. Recheck BP is 200/130 at 1644. Pt is awake, alert, oriented. She states that when she has anaphylaxis in the past, this is how it initially presents. Dr called at 1645 and notified of pt condition and advises to give epi and benadryl and call ems. EMS called at 1650 by RN. Pt requested to wait until EMS is closer to take epi as she said that it can make her blood pressure raise. At 1653, pt willing to take epi. Pt?s seat reclined. Epi pen 0.3mg given at 1653, Benadryl 50mg liquid given at 1654 by RN. EMS on site to take over care at 1655. Pt remains A&OX4 at this time. No difficulty breathing at this time. Pt remains fully conscious. Pt transferred to hospital in EMS. Pt notified that due to her having anaphylactic reaction to vaccine, she will not be able to receive another vaccine. Pt advised to follow up with PCP.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Erythema, Hypoaesthesia oral, Lip pruritus, Paraesthesia
Clinical narrative: Pt received shot at 1626. At 1637, pt reported that her lower lip felt itchy, cheeks were red. Pt has hx anaphylaxis to multiple food allergies and carries epi pen with her. At 1638, VS: BP 168/112, P 86, O2 100% RA.Lungs clear bilaterally. Pt then reported that her tongue felt ?numb? and ?pins and needles? sensations. Recheck BP is 200/130 at 1644. Pt is awake, alert, oriented. She states that when she has anaphylaxis in the past, this is how it initially presents. Dr called at 1645 and notified of pt condition and advises to give epi and benadryl and call ems. EMS called at 1650 by RN. Pt requested to wait until EMS is closer to take epi as she said that it can make her blood pressure raise. At 1653, pt willing to take epi. Pt?s seat reclined. Epi pen 0.3mg given at 1653, Benadryl 50mg liquid given at 1654 by RN. EMS on site to take over care at 1655. Pt remains A&OX4 at this time. No difficulty breathing at this time. Pt remains fully conscious. Pt transferred to hospital in EMS. Pt notified that due to her having anaphylactic reaction to vaccine, she will not be able to receive another vaccine. Pt advised to follow up with PCP.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Pain, Pain in extremity, Pyrexia
Clinical narrative: CHILLS; BODY ACHES; TIREDNESS; ARM PAIN; FEVER; This spontaneous report received from a patient concerned a 25 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no underlying/otherwise known health conditions.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 27-MAR-2021 13:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 27-MAR-2021, the subject experienced arm pain. On 27-MAR-2021, the subject experienced fever. On 27-MAR-2021 21:30, the subject experienced body aches. On 27-MAR-2021 21:30, the subject experienced tiredness. On 27-MAR-2021 22:30, the subject experienced chills. On 28-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 99.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, arm pain, fever, and tiredness on 28-MAR-2021. This report was non-serious.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Fatigue, Pain, Pain in extremity
Clinical narrative: CHILLS; BODY ACHES; TIREDNESS; ARM PAIN; FEVER; This spontaneous report received from a patient concerned a 25 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no underlying/otherwise known health conditions.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 27-MAR-2021 13:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 27-MAR-2021, the subject experienced arm pain. On 27-MAR-2021, the subject experienced fever. On 27-MAR-2021 21:30, the subject experienced body aches. On 27-MAR-2021 21:30, the subject experienced tiredness. On 27-MAR-2021 22:30, the subject experienced chills. On 28-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 99.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, arm pain, fever, and tiredness on 28-MAR-2021. This report was non-serious.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: CHILLS; BODY ACHES; TIREDNESS; ARM PAIN; FEVER; This spontaneous report received from a patient concerned a 25 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no underlying/otherwise known health conditions.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 27-MAR-2021 13:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 27-MAR-2021, the subject experienced arm pain. On 27-MAR-2021, the subject experienced fever. On 27-MAR-2021 21:30, the subject experienced body aches. On 27-MAR-2021 21:30, the subject experienced tiredness. On 27-MAR-2021 22:30, the subject experienced chills. On 28-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 99.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, arm pain, fever, and tiredness on 28-MAR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Injection site pain, Injection site swelling, Nausea
Clinical narrative: SORE NECK; RAW NERVES; SLIGHT SORENESS; SWELLING AT INJECTION SITE; MUSCLE ACHES; SLIGHT NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On APR-2021, the subject experienced sore neck. On APR-2021, the subject experienced raw nerves. On APR-2021, the subject experienced slight soreness. On APR-2021, the subject experienced swelling at injection site. On APR-2021, the subject experienced muscle aches. On APR-2021, the subject experienced slight nausea. On APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the slight soreness, swelling at injection site, muscle aches, sore neck, slight nausea, headache and raw nerves was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: SORE NECK; RAW NERVES; SLIGHT SORENESS; SWELLING AT INJECTION SITE; MUSCLE ACHES; SLIGHT NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On APR-2021, the subject experienced sore neck. On APR-2021, the subject experienced raw nerves. On APR-2021, the subject experienced slight soreness. On APR-2021, the subject experienced swelling at injection site. On APR-2021, the subject experienced muscle aches. On APR-2021, the subject experienced slight nausea. On APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the slight soreness, swelling at injection site, muscle aches, sore neck, slight nausea, headache and raw nerves was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site pain, Injection site swelling, Myalgia, Nausea
Clinical narrative: SORE NECK; RAW NERVES; SLIGHT SORENESS; SWELLING AT INJECTION SITE; MUSCLE ACHES; SLIGHT NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On APR-2021, the subject experienced sore neck. On APR-2021, the subject experienced raw nerves. On APR-2021, the subject experienced slight soreness. On APR-2021, the subject experienced swelling at injection site. On APR-2021, the subject experienced muscle aches. On APR-2021, the subject experienced slight nausea. On APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the slight soreness, swelling at injection site, muscle aches, sore neck, slight nausea, headache and raw nerves was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Nervous system disorder
Clinical narrative: SORE NECK; RAW NERVES; SLIGHT SORENESS; SWELLING AT INJECTION SITE; MUSCLE ACHES; SLIGHT NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On APR-2021, the subject experienced sore neck. On APR-2021, the subject experienced raw nerves. On APR-2021, the subject experienced slight soreness. On APR-2021, the subject experienced swelling at injection site. On APR-2021, the subject experienced muscle aches. On APR-2021, the subject experienced slight nausea. On APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the slight soreness, swelling at injection site, muscle aches, sore neck, slight nausea, headache and raw nerves was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Headache, Mobility decreased
Clinical narrative: CAN NOT WALK; LAY DOWN FOR 2 DAYS; SEVERE HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, administered on 01-APR-2021 at 14:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-APR-2021 17:30, the subject experienced can not walk. On 01-APR-2021 17:30, the subject experienced lay down for 2 days. On 01-APR-2021 17:30, the subject experienced severe headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lay down for 2 days on 03-APR-2021, and severe headache on 04-APR-2021, and the outcome of can not walk was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Hypokinesia, Mobility decreased
Clinical narrative: CAN NOT WALK; LAY DOWN FOR 2 DAYS; SEVERE HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, administered on 01-APR-2021 at 14:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-APR-2021 17:30, the subject experienced can not walk. On 01-APR-2021 17:30, the subject experienced lay down for 2 days. On 01-APR-2021 17:30, the subject experienced severe headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lay down for 2 days on 03-APR-2021, and severe headache on 04-APR-2021, and the outcome of can not walk was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Nausea
Clinical narrative: CAN NOT WALK; LAY DOWN FOR 2 DAYS; SEVERE HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, administered on 01-APR-2021 at 14:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-APR-2021 17:30, the subject experienced can not walk. On 01-APR-2021 17:30, the subject experienced lay down for 2 days. On 01-APR-2021 17:30, the subject experienced severe headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lay down for 2 days on 03-APR-2021, and severe headache on 04-APR-2021, and the outcome of can not walk was not reported. This report was non-serious.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Lip disorder
Clinical narrative: About 11 minutes after getting the shot, I began to feel light headed.  Laying down did not help.  They kept me for observation and over the next hour checked my blood pressure several times and it was very high. I think the highest reading was 187/110.  I have never had high blood pressure before.  They let me leave and said that I should see a doctor or go to the ER and that I probably just had high blood pressure now.  After I left I used a CVS model BP3MW1 -1W (800229) blood pressure cuff at home.  my blood pressure was now down to 153/83   The next morning I felt OK and went to work but left at 1 pm.  Shortly after had exhaustion, muscle aches, headache, and chills all evening and night heart rate was up to 128 beats per minuter .  Felt better the next day.  Am still experiencing, headaches and tiredness.  BP has been between 128/73 and 154/83.  I'm wondering if it is safe to get the second dose?
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Hypertension
Clinical narrative: About 11 minutes after getting the shot, I began to feel light headed.  Laying down did not help.  They kept me for observation and over the next hour checked my blood pressure several times and it was very high. I think the highest reading was 187/110.  I have never had high blood pressure before.  They let me leave and said that I should see a doctor or go to the ER and that I probably just had high blood pressure now.  After I left I used a CVS model BP3MW1 -1W (800229) blood pressure cuff at home.  my blood pressure was now down to 153/83   The next morning I felt OK and went to work but left at 1 pm.  Shortly after had exhaustion, muscle aches, headache, and chills all evening and night heart rate was up to 128 beats per minuter .  Felt better the next day.  Am still experiencing, headaches and tiredness.  BP has been between 128/73 and 154/83.  I'm wondering if it is safe to get the second dose?